⌘K
Amtech Esters Limited is engaged in the manufacturing and trading of Unsaturated Polyester Resins (UPRs) and complementary products such as Fiber Resin, hardeners, and ancillary items. The company boasts a diversified product portfolio of 79 SKUs, supported by strong quality assurance, ISO-certified processes, and in-house R&D capabilities.
Amtech Esters demonstrates strong financial health with impressive growth in revenue and profits, coupled with high return ratios and minimal debt. The IPO is attractively valued, and market sentiment is exceptionally positive, as evidenced by high subscription rates and a healthy GMP. While there are some data gaps, particularly in detailed risk disclosures and specific operational metrics, the overall picture points to a fundamentally sound company with good growth prospects.
The strong subscription across all categories, coupled with a healthy GMP and attractive valuation, indicates a high probability of significant listing gains.
Robust fundamentals, positive market sentiment, and reasonable valuation provide a strong foundation for short-term appreciation post-listing.
The company's strong financial growth, high return ratios, low debt, and outlined expansion strategies offer good potential for long-term value creation, assuming successful execution and sustained industry growth.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB | 11,29,600 | 47.38% | |
| NII (HNI) | 3,40,800 | 14.3% | |
| Retail | 7,93,600 | 33.29% | |
| Market Maker | 1,20,000 | 5.03% |
| Investor | |||
|---|---|---|---|
| HOLANI VENTURE CAPITAL FUND | 1,34,400 | ₹1.01 Cr | 19.86% |
| FLUMEN INVESTMENT TRUST-1729 GROWTH FUND I | 1,34,400 | ₹1.01 Cr | 19.86% |
| GENERATIONAL CAPITAL BREAKOUT FUND I | 1,36,000 | ₹1.02 Cr | 20.09% |
| VINEY GROWTH FUND | 1,36,000 | ₹1.02 Cr | 20.09% |
| KRUSHNAM NEXUS CAPITAL TRUST-KRUSHNAM NEXUS CAPITAL SCHEME 1 | 1,36,000 | ₹1.02 Cr | 20.09% |
Premium gain of 14.67% over issue price.
Strong financial performance with high revenue and PAT growth (CAGR > 20%).
Excellent return ratios (ROE 24.17%, ROCE 30.16%) and low debt (D/E 0.17).
Attractive valuation with a Post-IPO P/E of 15.69x and P/B of 2.71x.
Robust market sentiment indicated by high overall subscription (25.14x) and positive GMP (14.67% gain).
Diversified product portfolio (79 SKUs) and strong quality assurance with in-house R&D.
Experienced promoter and senior management team.
Industry growing at a healthy CAGR of 14.8%.
Successful execution of inorganic and organic expansion plans, deeper market penetration, and favorable industry tailwinds leading to higher demand for resins.
Consistent growth in line with industry trends, effective management of operational efficiencies, and steady demand for existing product lines.
Increased competition, significant volatility in raw material prices, economic slowdown impacting industrial demand, or unforeseen regulatory hurdles.
Positive: Strong financial growth (Revenue CAGR 22.8%, PAT CAGR 21.7%).
Concern: Promoter holding post-IPO (45.52%) is below the ideal 60% for an SME.
Listing-gain vs long-term: Apply / Apply.
Concern: Lack of detailed information on customer/supplier concentration.